Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Molecular Diagnosis & Therapy
|
March 2, 2017
Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs
Ariadna Tibau, Laura Díez-González, Beatriz Navarro, et al.
Plos One
|
May 6, 2016
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression
Arnoud J Templeton, Laura Diez Gonzalez, Francisco E Vera-Badillo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 24, 2021
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period
Aida Bujosa, Consolación Moltó, Thomas J Hwang, et al.
BMC Cancer
|
August 12, 2023
Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review
Josefina Salazar, Javier Bracchiglione, Olga Savall-Esteve, et al.
Journal of the National Cancer Institute
|
December 16, 2017
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
Ariadna Tibau, Consolación Molto, Alberto Ocana, et al.
Biomedicines
|
December 23, 2023
Secreted Protein Acidic and Rich in Cysteine (<i>SPARC)</i> Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients
Cristina Arqueros, Juliana Salazar, Alberto Gallardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2014
Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs
Ariadna Tibau, Philippe L Bedard, Amirrtha Srikanthan, et al.
International Journal of Molecular Sciences
|
March 13, 2024
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy
Cristina Arqueros, Alberto Gallardo, Silvia Vidal, et al.
Neoplasia (New York, N.Y.)
|
November 8, 2014
Chromosome 17 centromere duplication and responsiveness to anthracycline-based neoadjuvant chemotherapy in breast cancer
Ariadna Tibau, Laura López-Vilaró, Maitane Pérez-Olabarria, et al.
Therapeutic Advances in Medical Oncology
|
February 6, 2023
Quality of life with palbociclib plus fulvestrant <i>versus</i> placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial
Ariadna Tibau, M Teresa Martínez, Manuel Ramos, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Molecular Diagnosis & Therapy
|
March 2, 2017
Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs
Ariadna Tibau, Laura Díez-González, Beatriz Navarro, et al.
Plos One
|
May 6, 2016
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression
Arnoud J Templeton, Laura Diez Gonzalez, Francisco E Vera-Badillo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 24, 2021
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period
Aida Bujosa, Consolación Moltó, Thomas J Hwang, et al.
BMC Cancer
|
August 12, 2023
Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review
Josefina Salazar, Javier Bracchiglione, Olga Savall-Esteve, et al.
Journal of the National Cancer Institute
|
December 16, 2017
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
Ariadna Tibau, Consolación Molto, Alberto Ocana, et al.
Biomedicines
|
December 23, 2023
Secreted Protein Acidic and Rich in Cysteine (<i>SPARC)</i> Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients
Cristina Arqueros, Juliana Salazar, Alberto Gallardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2014
Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs
Ariadna Tibau, Philippe L Bedard, Amirrtha Srikanthan, et al.
International Journal of Molecular Sciences
|
March 13, 2024
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy
Cristina Arqueros, Alberto Gallardo, Silvia Vidal, et al.
Neoplasia (New York, N.Y.)
|
November 8, 2014
Chromosome 17 centromere duplication and responsiveness to anthracycline-based neoadjuvant chemotherapy in breast cancer
Ariadna Tibau, Laura López-Vilaró, Maitane Pérez-Olabarria, et al.
Therapeutic Advances in Medical Oncology
|
February 6, 2023
Quality of life with palbociclib plus fulvestrant <i>versus</i> placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial
Ariadna Tibau, M Teresa Martínez, Manuel Ramos, et al.
Page
of 5